Swarm Oncology
Pre-clinicalSwarm Oncology develops personalised T cell therapies that combine in vivo priming and ex vivo optimisation to deliver safe, potent, and durable treatments, driving cancers into long-term remission.
Founded
2018
Focus
Cell & Gene Therapy
About
Swarm Oncology develops personalised T cell therapies that combine in vivo priming and ex vivo optimisation to deliver safe, potent, and durable treatments, driving cancers into long-term remission.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile